Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 32Unknown 27Recruiting 22Terminated 9Not yet recruiting 8Active not recruiting 7Withdrawn 4Enrolling by invitation 4No longer available 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 158Pancreatic Neoplasms 148Carcinoma, Hepatocellular 127Colonic Neoplasms 79Stomach Neoplasms 58Rectal Neoplasms 58Liver Neoplasms 47Esophageal Neoplasms 46Breast Neoplasms 40Neoplasms 36Neoplasm Metastasis 35Cholangiocarcinoma 32Lung Neoplasms 23Gastrointestinal Neoplasms 20Ovarian Neoplasms 17Biliary Tract Neoplasms 15Carcinoma, Non-Small-Cell Lung 14Esophageal Squamous Cell Carcinoma 13Uterine Cervical Neoplasms 11Gallbladder Neoplasms 10Adenocarcinoma 10Sarcoma 9Carcinoma, Renal Cell 9Adenocarcinoma Of Esophagus 9Urinary Bladder Neoplasms 8Recurrence 8Bile Duct Neoplasms 8Prostatic Neoplasms 7Gastrointestinal Stromal Tumors 7Colonic Polyps 7

Interventions

Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Liver Cirrhosis × Gastrointestinal × Clear all
NCT05817994 2024-11-19

REGAL

Sheikh Shakhbout Medical City

Withdrawn
Gastrointestinal

Hepatitis, Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Liver Failure, Acute

NCT02899325 2023-02-21

FDGal PET/CT to Detect Hepatocellular Carcinoma

British Columbia Cancer Agency

Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

NCT02289300 2020-01-13

A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients

A2 Healthcare Taiwan Corporation

Phase 2 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis B, Chronic

NCT01501240 2014-01-28

PriMPa

Asan Medical Center

Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡